Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Retained Earnings (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Retained Earnings for 5 consecutive years, with -$475.4 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 14.67% to -$475.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$475.4 million through Dec 2025, down 14.67% year-over-year, with the annual reading at -$475.4 million for FY2025, 14.67% down from the prior year.
  • Retained Earnings for Q4 2025 was -$475.4 million at Werewolf Therapeutics, down from -$467.0 million in the prior quarter.
  • The five-year high for Retained Earnings was -$153.8 million in Q1 2021, with the low at -$475.4 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$335.3 million, with a median of -$327.9 million recorded in 2023.
  • The sharpest move saw Retained Earnings plummeted 74.46% in 2022, then dropped 12.18% in 2023.
  • Over 5 years, Retained Earnings stood at -$252.9 million in 2021, then fell by 21.28% to -$306.7 million in 2022, then dropped by 12.18% to -$344.1 million in 2023, then dropped by 20.49% to -$414.6 million in 2024, then fell by 14.67% to -$475.4 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$475.4 million, -$467.0 million, and -$450.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.